Detalhe da pesquisa
1.
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding.
Glycobiology
; 33(7): 591-604, 2023 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37341346
2.
Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell priming to promote memory formation and metabolic readiness.
J Immunol
; 194(5): 2089-98, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25624453
3.
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models.
Sci Transl Med
; 14(670): eabn1082, 2022 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36350988
4.
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses.
Sci Immunol
; 6(58)2021 04 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33837124
5.
Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility.
Cancer Immunol Res
; 2(10): 970-80, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25038199
6.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
J Exp Med
; 210(9): 1695-710, 2013 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-23897981